Company intelligence / Profile preview
C4 Therapeutics
Watertown, Massachusetts, United Statesc4therapeutics.com ↗
- Ownership
- Public · CCCC
- Employees
- ~100
- Development stage
- Other
01
Overview
C4 Therapeutics has early-stage clinical and pre-clinical programs focused on oncology and severe diseases, leveraging its DGPD protein degradation platform; public clinical data is limited as most assets are in early development.
- Therapeutic areas
- OncologyRare Diseases
- Modalities
- Proteolysis-targeting chimera therapySmall molecule
- Industry
- Biotech
02
Drug pipeline
7 assets6 more assets in the full pipeline.
03
Partnerships
Strategic partnerships with major pharma
04
Financials
- Market cap
- $362.9M
- Total revenue
- $35.9M
- Enterprise value
- $212.8M
Beyond the preview
Go deeper on C4 Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on C4 Therapeutics.